The drug, named bapineuzumab, appears to slow the devastating effects of Alzheimer's by targeting amyloid plaques, which accumulate in the brain and detrimentally impact nerve cells in the brain. The plaque build-up results in symptoms of memory loss and difficulty performing routine tasks
